Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – The nonhuman animal is a model for human disease
Reexamination Certificate
2006-04-28
2010-02-16
Crouch, Deborah (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
The nonhuman animal is a model for human disease
C800S018000, C800S025000, C800S003000, C435S354000, C435S029000
Reexamination Certificate
active
07663018
ABSTRACT:
Animal model involving transgenic manipulation of amyloid precursor protein, useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease.
REFERENCES:
patent: 5877399 (1999-03-01), Hsiao
patent: 93/14200 (1993-07-01), None
patent: 94/12627 (1994-06-01), None
patent: 95/11968 (1995-05-01), None
patent: 96/06927 (1996-03-01), None
patent: 98/03644 (1998-01-01), None
Andrä K. et al., Neurobiology of Aging, vol. 17 (2), “Expression of APP in Transgenic Mice: A Comparison of Neuron-Specific Promotors,” pp. 183-190 (1996).
Chartier-Harlin, M-C et al., Nature, vol. 353, “Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene,” pp. 844-846 (1991).
Games D. et al., Nature, vol. 373, “Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein,” pp. 523-527 (1995).
P M Moran et al, PNAS Age related deficits in transgenic mice expressing the 751-amino acid isoform of human B-amyloid precursor protein, Jun. 1995, pp. 5341-5345.
KM Felsenstein, Alzheimer's and Parkinson's Diseases, Transgenic Rat and In-vitro Studies of B-amyloid precursor protein Processing, Plenum Press, NY, 1995, pp. 401-409.
L Lannfelt et al, Behaviorial Brian Research, Alzheimer's Disease: molecular genetics and transgenic animal models, 1993, 57, pp. 207-213.
LSHiggins, Annals NYAcedemy of Sciences, “Transgenic mice Expressing Human B-APP751, But not Mice Expressing B-APP695, Display Early Alzheimer's Diosease-like Histopathology”, pp. 224-227.
Kaesermann H., Psychopharmacology, vol. 89, “Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action*,” pp. 31-37 (1986).
Kang J. et al., Nature, vol. 325, “The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor,” pp. 733-736 (1987).
Kitaguchi N., Nature, vol. 331, “Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity,” pp. 530-532 (1988).
Levy E. et al., Science, vol. 248, “Mutation of the Alzhelmer's Disease Amyloid Gene: Hereditary Cerebral Hemorrhage, Dutch Type,” p. 1124-1126 (1990).
Mega M. et al., Neurology, vol. 46, “The spectrum of behavioral changes in Alzheimer's disease,” pp. 130-135 (1996).
Moechars D. et al, EMBO Journal, vol. 15 (6), “Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice,” pp. 1265-1274 (1996).
Morris R.G.M. et al., Nature, vol. 297 , “Place navigation impaired in rats with hippocampal lesions,” pp. 681-683 (1982).
Quon D. et al., Nature, vol. 352, “Formation of β-amyloid protein deposits in brains of transgenic mice,” pp. 239-241 (1991).
Schmidt E.V. et al., Molecular and Cellular Biology, vol. 10, “The Cytomegalovirus Enhancer: a Pan-Active Control Element in Transgenic Mice,” pp. 4406-4411 (1990).
Sommer B. et al., Society for Neuroscience Abstracts 22:25 XP002049073, “Animal Models for Alzheimer's Disease Based on Genetics and Pathology,” (Nov. 16, 1996).
Thiel G. et al., Proc. Natl. Acad. Sci. USA, vol. 88, “Characterization of tissue-specific transcription by the human synapsin I gene promoter,” pp. 3431-3435 (1991).
Vidal M. et al., EMBO Journal, vol. 9 (3), “Tissue-specific control elements of the Thy-1 gene,” pp. 833-840 (1990).
Wirak D.O. et al., Science, vol. 253, “Deposits of Amyloid β Protein in the Central Nervous System of Transgenic Mice,” pp. 323-325 (1991).
Yankner B. et al., Science, vol. 245, “Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease,” pp. 417-420 (1989).
Hsiao et al., Science, vol. 274, pp. 99-102 (1996).
Sommer Bernd
Stauffenbiel Matthias
Crouch Deborah
Novartis AG
LandOfFree
Tau hyperphosphorylation in transgenic mice expressing the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tau hyperphosphorylation in transgenic mice expressing the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tau hyperphosphorylation in transgenic mice expressing the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206726